ArticleDrugs - real world outcomes2016

Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study.

Tao Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.